Skip to main content

Rein Therapeutics, Inc.

RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420565

No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Rein Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
42
0 vs. Q4 2021
Shares held
32.2M
−1.32M (−3.9%) vs. Q4 2021
Total value
$16.5M
−$2.36M (−12.5%) vs. Q4 2021
New holders
7
6 more added
Sold out
7
13 more reduced

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 42 institutions
Q1 2021: 52 institutionsQ2 2021: 47 institutionsQ3 2021: 43 institutionsQ4 2021: 43 institutionsQ1 2022: 42 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 19 institutionsQ1 2023: 19 institutionsQ2 2023: 17 institutionsQ3 2023: 16 institutionsQ4 2023: 20 institutionsQ1 2024: 23 institutionsQ2 2024: 29 institutionsQ3 2024: 32 institutionsQ4 2024: 31 institutionsQ1 2025: 39 institutionsQ2 2025: 36 institutionsQ3 2025: 40 institutionsQ4 2025: 48 institutionsQ1 2026: 46 institutionsQ2 2026: 59 institutions
Value heldQ1 2022: $16.5M
Q1 2021: $48.0MQ2 2021: $41.5MQ3 2021: $33.6MQ4 2021: $18.9MQ1 2022: $16.5MQ2 2022: $8.34MQ3 2022: $5.86MQ4 2022: $3.21MQ1 2023: $1.30MQ2 2023: $1.83MQ3 2023: $1.59MQ4 2023: $3.24MQ1 2024: $11.0MQ2 2024: $13.5MQ3 2024: $16.3MQ4 2024: $13.1MQ1 2025: $10.6MQ2 2025: $9.30MQ3 2025: $9.76MQ4 2025: $12.5MQ1 2026: $14.8MQ2 2026: $42.3M
Institutions holding RNTX and their total value by quarter
QuarterHoldersValue
Q2 202659$42.3M
Q1 202646$14.8M
Q4 202548$12.5M
Q3 202540$9.76M
Q2 202536$9.30M
Q1 202539$10.6M
Q4 202431$13.1M
Q3 202432$16.3M
Q2 202429$13.5M
Q1 202423$11.0M
Q4 202320$3.24M
Q3 202316$1.59M
Q2 202317$1.83M
Q1 202319$1.30M
Q4 202219$3.21M
Q3 202233$5.86M
Q2 202237$8.34M
Q1 202242$16.5M
Q4 202143$18.9M
Q3 202143$33.6M
Q2 202147$41.5M
Q1 202152$48.0M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding RNTX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Satter Management Co., L.P.16,609,449$8.51M14.42%00.0%Unchanged
BVF Inc5,265,555$2.70M0.11%00.0%Unchanged
Vanguard Group Inc3,093,228$1.58M0.00%−332,884−9.7%Reduced
Ikarian Capital, LLC2,902,086$1.49M0.45%+138,503+5.0%Added
Blair William & Co1,006,668$516.0K0.00%−60,821−5.7%Reduced
Geode Capital Management, LLC867,777$444.0K0.00%+5,775+0.7%Added
KCK Ltd.646,817$331.0K0.32%00.0%Unchanged
Boothbay Fund Management, LLC278,743$143.0K0.00%00.0%Unchanged
BlackRock Inc.194,200$100.0K0.00%−9,288−4.6%Reduced
Taconic Capital Advisors LP135,000$69.0K0.00%00.0%Unchanged
Bailard, Inc.128,010$66.0K0.00%+128,010New
Northern Trust Corp127,883$65.0K0.00%00.0%Unchanged
Envestnet Asset Management Inc120,058$62.0K0.00%−16,702−12.2%Reduced
Morgan Jess S & Co Inc100,000$51.0K0.04%00.0%Unchanged
Game Plan Financial Advisors, LLC93,000$48.0K0.03%+5,000+5.7%Added
Colony Group LLC90,318$46.0K0.00%+90,318New
State Street Corp71,200$36.0K0.00%00.0%Unchanged
Renaissance Technologies LLC58,500$30.0K0.00%−411,940−87.6%Reduced
Advisor Group Holdings, Inc.40,590$21.0K0.00%+1,597+4.1%Added
Jane Street Group, LLC34,856$18.0K0.00%−7,865−18.4%Reduced
JFS Wealth Advisors, LLC31,807$16.0K0.00%00.0%Unchanged
Morgan Stanley29,429$15.0K0.00%−668,293−95.8%Reduced
Kestra Advisory Services, LLC30,000$15.0K0.00%00.0%Unchanged
Citigroup Inc30,126$15.0K0.00%+30,126New
Keebeck Wealth Management, LLC27,000$14.0K0.00%−43,000−61.4%Reduced
US Bancorp25,000$13.0K0.00%00.0%Unchanged
Virtu Financial LLC21,348$11.0K0.00%+21,348New
Mercer Global Advisors Inc20,096$10.0K0.00%−2,011−9.1%Reduced
Lake Street Advisors Group, LLC18,500$10.0K0.00%00.0%Unchanged
Cetera Investment Advisers17,497$9.00K0.00%−842−4.6%Reduced
Kovack Advisors, Inc.15,000$7.00K0.00%+15,000New
UBS Group AG11,120$6.00K0.00%−12,248−52.4%Reduced
HighTower Advisors, LLC12,000$6.00K0.00%00.0%Unchanged
Kore Private Wealth LLC11,183$6.00K0.00%00.0%Unchanged
LPL Financial LLC10,000$5.00K0.00%00.0%Unchanged
Ridgecrest Wealth Partners, LLC10,000$5.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)9,939$5.00K0.00%+8,877+835.9%Added
Bank of America Corp7,700$4.00K0.00%−125−1.6%Reduced
JPMorgan Chase & Co1,096$1.00K0.00%+1,096New
Acadian Asset Management LLC344$00.00%−84,930−99.6%Reduced
Wells Fargo & Company407$00.00%+1+0.2%Added
Rockefeller Capital Management L.P.1,000$00.00%+1,000New
Two Sigma Securities, LLC0$00.00%−34,663−100.0%Sold out
Millennium Management LLC0$00.00%−31,548−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−10,800−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−10,069−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−11,300−100.0%Sold out
HRT Financial LP0$00.00%−10,630−100.0%Sold out
Spire Wealth Management0$00.00%−2,249−100.0%Sold out
PVG Asset Management Corp––––Not filed